Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PMEP: Inhaled Vancomycin for Persistent MRSA in Cystic Fibrosis
NCT01594827Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Oct 2012
- Primary completion
- Dec 2017
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vancomycin in cystic fibrosis (CF), sponsored by Johns Hopkins University. Started Oct 2012; status: completed.
02
Drugs
vancomycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01594827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01594827.